This subproject is one of many research subprojects utilizing theresources provided by a Center grant funded by NIH/NCRR. The subproject andinvestigator (PI) may have received primary funding from another NIH source,and thus could be represented in other CRISP entries. The institution listed isfor the Center, which is not necessarily the institution for the investigator.Hypoglycemia is a critical factor limiting optimal care in Type 1 diabetes patient (T1DM). Recurrent hypoglycemia can led to hypoglycemia unawareness (HU). However, little is know about the neural pathways underlying the changes in glucose sensing, cortical activity, and cognition associate with HU. The proposed studies will use fMRI to examine brain activation, cognitive performance, counter regulatory hormone secretion, and symptom recognition in three carefully selected contrast groups (N=60). T1DM patients without HU, T1DM patients with HU and non-diabetic volunteers to determine whether the counter regulatory defect present in unaware patients occurs due to an abnormal hypothalamic response. We will further explore whether other brain regions are activated in response to hypoglycemia and whether these regions differ in aware T1DM patients and control subjects as compared with the unaware patients. We will also investigate cortical activation in areas that support cognition. This research program will allow us to identify the brain regions involved in glucose sensing as well as cortical regions most susceptible to hypoglycemia. Due to the therapeutic goal of maintaining blood glucose levels as near normal, there is an elevated risk for mild recurrent hypoglycemia in T1DM. We need to better understand the long-term sequelae of this phenomenon to design approaches to clinical care to help patients achieve tighter glycemic control. Further a better understanding of the neural underpinnings of hypoglycemia associated cognitive impairments could provide important guidance on how to anticipate, avoid, and adapt to specific cognitive limitation that may be caused by an unanticipated hypoglycemic event. A major aim of our study is to determine whether patients with hypoglycemia unawareness activate the glucose sensing region (hypothalamus) less strongly and a t a lower blood glucose than aware diabetic patients and control subjects and whether they respond differently to cognitive challenges during hypoglycemia.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
General Clinical Research Centers Program (M01)
Project #
5M01RR001032-33
Application #
7718977
Study Section
National Center for Research Resources Initial Review Group (RIRG)
Project Start
2008-04-01
Project End
2008-05-31
Budget Start
2008-04-01
Budget End
2008-05-31
Support Year
33
Fiscal Year
2008
Total Cost
$1,900
Indirect Cost
Name
Beth Israel Deaconess Medical Center
Department
Type
DUNS #
071723621
City
Boston
State
MA
Country
United States
Zip Code
Nowak, Kristen L; You, Zhiying; Gitomer, Berenice et al. (2018) Overweight and Obesity Are Predictors of Progression in Early Autosomal Dominant Polycystic Kidney Disease. J Am Soc Nephrol 29:571-578
Chung, Chen-Chih; Pimentel Maldonado, Daniela A; Jor'dan, Azizah J et al. (2018) Lower cerebral vasoreactivity as a predictor of gait speed decline in type 2 diabetes mellitus. J Neurol 265:2267-2276
Kline, Emily R; Seidman, Larry J; Cornblatt, Barbara A et al. (2018) Depression and clinical high-risk states: Baseline presentation of depressed vs. non-depressed participants in the NAPLS-2 cohort. Schizophr Res 192:357-363
Simpson, Norah S; Scott-Sutherland, Jennifer; Gautam, Shiva et al. (2018) Chronic exposure to insufficient sleep alters processes of pain habituation and sensitization. Pain 159:33-40
Dai, Weiying; Duan, Wenna; Alfaro, Freddy J et al. (2017) The resting perfusion pattern associates with functional decline in type 2 diabetes. Neurobiol Aging 60:192-202
Brosnahan, Godela M; Abebe, Kaleab Z; Rahbari-Oskoui, Frederic F et al. (2017) Effect of Statin Therapy on the Progression of Autosomal Dominant Polycystic Kidney Disease. A Secondary Analysis of the HALT PKD Trials. Curr Hypertens Rev 13:109-120
Torres, Vicente E; Abebe, Kaleab Z; Schrier, Robert W et al. (2017) Dietary salt restriction is beneficial to the management of autosomal dominant polycystic kidney disease. Kidney Int 91:493-500
Irazabal, María V; Abebe, Kaleab Z; Bae, Kyongtae Ty et al. (2017) Prognostic enrichment design in clinical trials for autosomal dominant polycystic kidney disease: the HALT-PKD clinical trial. Nephrol Dial Transplant 32:1857-1865
Seidman, Larry J; Shapiro, Daniel I; Stone, William S et al. (2016) Association of Neurocognition With Transition to Psychosis: Baseline Functioning in the Second Phase of the North American Prodrome Longitudinal Study. JAMA Psychiatry 73:1239-1248
Thermenos, Heidi W; Juelich, Richard J; DiChiara, Samantha R et al. (2016) Hyperactivity of caudate, parahippocampal, and prefrontal regions during working memory in never-medicated persons at clinical high-risk for psychosis. Schizophr Res 173:1-12

Showing the most recent 10 out of 642 publications